Relay Therapeutics, Inc.

Contributing Author

Recent Articles by Relay Therapeutics, Inc.

Dec-12	Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025 RLAY GlobeNewswire
Nov-06	Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates RLAY GlobeNewswire
Nov-03	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November RLAY GlobeNewswire
Oct-30	Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 RLAY GlobeNewswire
Aug-28	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September RLAY GlobeNewswire
Aug-07	Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates RLAY GlobeNewswire
Jul-31	Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 RLAY GlobeNewswire
Jun-11	Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors RLAY GlobeNewswire
Jun-02	Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 RLAY GlobeNewswire
May-29	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June RLAY GlobeNewswire
May-08	Relay Therapeutics to Participate in Two Upcoming Investor Conferences RLAY GlobeNewswire
May-05	Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates RLAY GlobeNewswire